Graham J, Earnshaw S, Lim J, Luthra R, Borker R. Cost-effectiveness of afatinib versus erlotinib in the first-line treatment of patients with metastatic non-small cell lung cancer with EGFR Exon 19 deletion mutations. JCP. 2016 May;2(4):31-9.
Carney RSE, Bystron I, Lopez-Bendito G, Molnar Z. Comparative analysis of extra-ventricular mitoses at early stages of cortical development in rat and human. Brain Struct Funct. 2007 Jul;212(1):37-54. doi: 10.1007/s00429-007-0142-4